Synlogic, Inc. (SYBX)
NASDAQ: SYBX · Real-Time Price · USD
1.360
-0.070 (-4.90%)
Feb 21, 2025, 4:00 PM EST - Market closed
Synlogic Revenue
Synlogic had revenue of $2.78M in the twelve months ending September 30, 2024, up 292.23% year-over-year. In the year 2023, Synlogic had annual revenue of $3.37M with 185.68% growth.
Revenue (ttm)
$2.78M
Revenue Growth
+292.23%
P/S Ratio
5.95
Revenue / Employee
$462,833
Employees
6
Market Cap
15.91M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SYBX News
- 3 months ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 10 months ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 1 year ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire
- 1 year ago - Synlogic Provides Corporate Update and Outlook for 2024 - GlobeNewsWire